Search Count: 14
 |
Structure Of At118-H Nanobody Antagonist In Complex With The Angiotensin Ii Type I Receptor
Organism: Camelidae, Homo sapiens, Escherichia coli, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2024-05-22 Classification: SIGNALING PROTEIN/IMMUNE SYSTEM Ligands: Y01 |
 |
Structure Of At118-L Nanobody Antagonist In Complex With The Angiotensin Ii Type I Receptor And Losartan
Organism: Homo sapiens, Escherichia coli, Synthetic construct
Method: ELECTRON MICROSCOPY Release Date: 2024-05-22 Classification: SIGNALING PROTEIN/IMMUNE SYSTEM Ligands: LSN |
 |
Structural Basis For Enhanced Infectivity And Immune Evasion Of Sars-Cov-2 Variants
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Resolution:2.90 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Structural Basis For Enhanced Infectivity And Immune Evasion Of Sars-Cov-2 Variants
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Resolution:3.11 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Structural Basis For Enhanced Infectivity And Immune Evasion Of Sars-Cov-2 Variants
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2021-07-07 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Structural Basis For Enhanced Infectivity And Immune Evasion Of Sars-Cov-2 Variants
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Resolution:3.21 Å Release Date: 2021-07-07 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Structural Basis For Enhanced Infectivity And Immune Evasion Of Sars-Cov-2 Variants
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2021-07-07 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Structural Basis For Enhanced Infectivity And Immune Evasion Of Sars-Cov-2 Variants
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2021-07-07 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Structural Basis For Enhanced Infectivity And Immune Evasion Of Sars-Cov-2 Variants
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2021-07-07 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Resolution:3.40 Å Release Date: 2021-03-31 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Resolution:3.50 Å Release Date: 2021-03-24 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Resolution:3.20 Å Release Date: 2021-03-24 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2020-07-22 Classification: VIRAL PROTEIN Ligands: NAG |
 |
Organism: Severe acute respiratory syndrome coronavirus 2
Method: ELECTRON MICROSCOPY Release Date: 2020-07-22 Classification: VIRAL PROTEIN Ligands: NAG, MAN |